干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 641526|回复: 242
go

[干细胞与细胞生物学类] PDF电子书:The Immunological Barriers to Regenerative Medicine (2013) [复制链接]

Rank: 2

积分
74 
威望
74  
包包
70  
楼主
发表于 2013-5-16 09:24 |只看该作者 |正序浏览 |打印
ABOUT THIS BOOK) s2 }: {6 L2 |$ O5 Z& F
- c- E/ b9 r3 \6 W+ @" g/ t
Editors:  Paul J. Fairchild 0 N$ A  R" S% V% w. q
Series:  Stem Cell Biology and Regenerative Medicine# [# b) b1 g! a+ T! F: _
Publisher:  Humana Press Springer-Verlag New York Inc.
! d" m, v& q. F$ |; E: ZPublication Date:  October 17, 2012
2 k& w; y* J7 [, |# ^* ^6 f) KEdition: 2013
. t# M9 a& H4 L  K8 I4 oLanguage:  English
) S# U  m6 h; K/ F! K' w7 ?5 r, OHardcover:  347 pages
! [; b- M% b1 b! {8 v2 N8 QISBN:  978-1-4614-5479-3
7 _+ V1 m" k8 @* OISBN:  978-1-4614-5480-9 (eBook)% ^/ O4 J! \6 C) G8 Q1 }" E

+ k5 E1 i: X/ |' p  |6 N► Explores the extent to which the principles of allograft rejection, learned over several decades from our experiences of whole organ transplantation, apply within the unique context of cell replacement therapy0 h" I# e5 [( z6 }# }
► Discusses various innovative ways of addressing the issues of immunogenicity) k: }8 x1 W6 ~  ^, q( v
► Focuses exclusively on the induction of immunological tolerance through a variety of novel approaches
9 K  n! V" h' h# k+ q5 s4 c* m  q( I1 w" u
Recent years have witnessed numerous advances in stem cell research that have suggested novel strategies for the treatment of the chronic and regenerative diseases that pose a growing challenge to the provision of healthcare in the 21st century.  Nevertheless, there is little doubt that related disciplines have failed to keep pace with such developments, of which the immunology of transplant rejection is perhaps the most relevant to the nascent field of regenerative medicine.  Indeed, given that after decades of research into the mechanisms of organ allograft rejection, we remain wholly dependent on immune suppression to ensure acceptance of foreign tissues, we might legitimately ask whether there is any reason why tissues differentiated from stem cells might not suffer the same fate.  This volume seeks to address this issue by drawing on the principles of alloantigen recognition to assess the validity of early convictions that embryonic stem cell-derived tissues may prove invisible to the immune system of the host and the more recent belief that induced pluripotent stem cells, derived in a fully autologous manner, will circumvent the issue of immunogenicity.  Having debunked such assumptions and established the magnitude of the immunological barriers to be overcome, this book then draws on the expertise of internationally-recognised laboratories around the world to provide a critical assessment of the likely success of applying strategies such as stem cell banking, silencing of genes that confer immunogenicity, and the induction of transplantation tolerance to overcoming the immunological barriers in the future.  Indeed, it is only through reaching a consensus in the field that enduring solutions to such an intractable problem may ultimately emerge.% z0 F! g9 N* c& }" `+ x( p

, @% ]" L5 t% c5 Z3 ZAbout the Editor% w7 u' o6 w* k8 \5 j

9 H- @+ F. h" e( o5 H2 MDr Paul Fairchild began his research career in Oxford, where he studied for a doctorate in the Nuffield Department of Surgical Sciences, focussing on the immune response to organ allografts. After spending five years as a post-doctoral fellow investigating the etiology of autoimmune disease in the Department of Pathology, University of Cambridge, he returned to Oxford, where he is currently a University Lecturer in Pre-clinical Medicine within the Sir William Dunn School of Pathology and a Fellow of Trinity College. In 2008, Paul Fairchild founded the Oxford Stem Cell Institute (OSCI), for which he currently serves as Co-Director.9 ~% b- r% C. }5 d: x$ {
As a highly interdisciplinary organization, the OSCI focuses on exploiting the properties of stem cells for the treatment of some of the most intractable chronic and egenerative diseases. It is within this context that he continues to apply his background in transplantation immunology, in order to investigate the nature of the immune response to tissues differentiated from pluripotent stem cells, and develop approaches to the induction and maintenance of immunological tolerance.
8 U2 k' Q) ~; c$ W
附件: 你需要登录才可以下载或查看附件。没有帐号?注册

Rank: 2

积分
116 
威望
116  
包包
1832  
243
发表于 2024-5-5 19:42 |只看该作者
感觉好像在哪里看过了,汗~  

Rank: 2

积分
72 
威望
72  
包包
1670  
242
发表于 2024-4-7 00:02 |只看该作者
干细胞行业  

Rank: 2

积分
71 
威望
71  
包包
1627  
241
发表于 2024-3-29 09:35 |只看该作者
干细胞之家微信公众号
世界上那些最容易的事情中,拖延时间最不费力。  

Rank: 2

积分
64 
威望
64  
包包
1796  
240
发表于 2024-3-25 14:58 |只看该作者
真是天底下好事多多  

Rank: 2

积分
72 
威望
72  
包包
1859  
239
发表于 2024-3-10 02:43 |只看该作者
我等你哟!  

Rank: 2

积分
135 
威望
135  
包包
1750  
238
发表于 2024-2-26 19:43 |只看该作者
我等你哟!  

Rank: 2

积分
75 
威望
75  
包包
2193  
237
发表于 2024-2-23 21:59 |只看该作者
不错,支持下  

Rank: 2

积分
88 
威望
88  
包包
1897  
236
发表于 2023-12-1 19:37 |只看该作者
每天早上起床都要看一遍“福布斯”富翁排行榜,如果上面没有我的名字,我就去上班……  

Rank: 2

积分
88 
威望
88  
包包
1769  
235
发表于 2023-12-1 18:52 |只看该作者
正好你开咯这样的帖  
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-5-13 08:06

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.